Coronavirus: latest information
Grove Front Entrance.jpg
Dr Gill Conway

Dr Gill Conway

Research Officer/Laboratory Manager, Medicine

Telephone number

+44 (0) 1792

Research Links

Open Plan Office - 403
Fourth Floor
Institute of Life Science 1
Singleton Campus
Available For Postgraduate Supervision

About

Dr. Conway is a Research officer and lab manager in the In Vitro Toxicology group within Swansea University Medical School. She completed her BSc in Bio-molecular Science and a PhD in the area of molecular biology and cancer therapeutics at the Technological University Dublin, Ireland. She has also previously worked at the National Institute for Bioprocessing research and training (NIBRT) in Ireland before coming to Swansea University.

Areas Of Expertise

  • Cancer biology
  • Advanced in vitro cellular models
  • Nutraceuticals
  • Cell signalling
  • Genetic Toxicology
  • DNA damage

Career Highlights

Research

Dr. Conway is part of the In Vitro Toxicology Group led by Prof Shareen Doak. Her research within the group focuses on the development of predictive in vitro models and bioassays to support engineered nanomaterial hazard assessment. The overarching aim of these developments is to reduce the reliance on animal experimentation. 
 
Gillian also has a particular interest in investigating novel therapeutic approaches for the treatment of cancer. Improvements in the detection and treatment of cancer has led to increased average survival rates that are now six times longer than those reported forty years ago. However, a number of cancers remain resistant to most treatments, resulting in a high rate of tumour reoccurrence. Gillian’s research focuses on the investigation of naturally derived bioactive compounds as novel therapeutic approaches for the treatment of brain cancer. 

Award Highlights

Gillian was awarded the St. David's Medical Foundation early career researcher grant to carry out the project titled ‘Investigate the efficacy of plant derived bioactive compounds in a three-dimensional (3D) in vitro Glioblastoma Multiforme model’ (2020).

Collaborations

Prof. James Curtin (Technological University Dublin) 
Dr Shane Heffernan (College of Engineering, Swansea University)